Interleukin-9 could inhibit melanoma
Mice without the genes responsible for the development of the T helper 17 (TH17) cell demonstrated significant resistance to melanoma tumor growth.
Mice without the genes responsible for the development of the T helper 17 (TH17) cell demonstrated significant resistance to melanoma tumor growth.
Researchers are investigating the use of genomics to achieve better cure rates with less morbidity in patients undergoing radiation treatment.
Combination therapy may be a promising treatment approach for patients with advanced melanoma who experience the abscopal effect.
A long-term study indicated that imatinib is the treatment of choice for people with chronic myeloid leukemia who do not respond to interferon.
A recent trial indicates that a viral therapy delivered intravenously can consistently infect and spread within tumors without harming normal tissue in humans.
Women recovering from breast cancer choose biological-based therapies, according to findings published in Nursing Research (2010 Jan-Feb;59(1):58-66).